Unknown

Dataset Information

0

Epidemiology of vulvar neoplasia in the NIH-AARP Study.


ABSTRACT: OBJECTIVE:To clarify risk factors for rare vulvar neoplasms. METHODS:Within the NIH-AARP Study, among 201,469 women interviewed in 1995-1996 and followed for a mean of 13.8years, there were 370 diagnoses of incident vulvar neoplasms, including 170 invasive and 198 vulvar intraepithelial neoplasms grade 3 (VIN3). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated via multivariate logistic regression for various demographic, reproductive and lifestyle factors, with separate consideration of relations according to invasiveness, histology and age at diagnosis. RESULTS:Consistent with descriptive data, we found non-white women at lower risks of vulvar neoplasia than white women (HR=0.59, 95% CI 0.36-0.95). Significant risk factors for VIN3 included being divorced/separated (HR vs. currently married=1.77, 95% CI 1.24-2.51), a current cigarette smoker (3.88, 95% CI 2.64-5.72), a user of oral contraceptives (1.46, 95% CI 1.06-2.01), or a current user of menopausal hormones (1.73, 95% CI 1.24-2.41). Significant risk factors for invasive cancers were being obese (HR for BMI ?30 vs. <25=1.62, 95% CI 1.10-2.40) or a current smoker (1.86, 95% CI 1.21-2.87). Cigarette smoking was a risk factor mainly for neoplasms shown in other investigations to be HPV-related, namely VIN3 and invasive squamous cell cancers (SCCs) occurring in the younger stratum of cases. In contrast, obesity was primarily associated with the development of invasive SCCs. CONCLUSIONS:Our results support that vulvar neoplasia is a heterogeneous disease. VIN3 demonstrated risk factors consistent with an HPV-related etiology, while invasive cancers were additionally affected by obesity, suggesting that further attention should focus on the role of chronic inflammatory conditions.

SUBMITTER: Brinton LA 

PROVIDER: S-EPMC5629039 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epidemiology of vulvar neoplasia in the NIH-AARP Study.

Brinton Louise A LA   Thistle Jake E JE   Liao Linda M LM   Trabert Britton B  

Gynecologic oncology 20170222 2


<h4>Objective</h4>To clarify risk factors for rare vulvar neoplasms.<h4>Methods</h4>Within the NIH-AARP Study, among 201,469 women interviewed in 1995-1996 and followed for a mean of 13.8years, there were 370 diagnoses of incident vulvar neoplasms, including 170 invasive and 198 vulvar intraepithelial neoplasms grade 3 (VIN3). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated via multivariate logistic regression for various demographic, reproductive and lifestyle factors, with  ...[more]

Similar Datasets

| S-EPMC5017779 | biostudies-literature
| S-EPMC3985213 | biostudies-literature
| S-EPMC7515486 | biostudies-literature
| S-EPMC4656060 | biostudies-literature
| S-EPMC4311176 | biostudies-literature
| S-EPMC7870624 | biostudies-literature
| S-EPMC8699429 | biostudies-literature
| S-EPMC3494407 | biostudies-literature
| S-EPMC4047159 | biostudies-literature
| S-EPMC5005936 | biostudies-literature